Literature DB >> 20204708

Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study.

Nan Luo1, Wai-Yee Ng, Puay-Ngoh Lau, Wing-Lok Au, Louis Cs Tan.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the responsiveness of the EQ-5D and the Parkinson's Disease Questionnaire (PDQ-8) to deterioration in health-related quality of life (HRQoL) in patients with Parkinson's disease (PD).
METHODS: HRQoL and clinical data collected from 31 patients with PD (male: 74.2%, mean age: 61 years) who were surveyed with the EQ-5D and the PDQ-8 questionnaires in 2002 and 2006/2007 were analyzed. Responsiveness of the EQ-5D, PDQ-8, and Hoehn and Yahr (H&Y) staging were assessed according to Cohen's effect size (ES) and standardized response mean (SRM).
RESULTS: The mean (standard deviation) EQ-5D index and PDQ-8 summary index (PDQ-8SI) scores were 0.76 (0.23) and 17.7 (14.2) at baseline and 0.52 (0.33) and 35.1 (17.4) at year four. Based on both ES and SRM indices, the rank order of responsiveness of the studied measures, from high to low, was PDQ-8SI (ES = 1.22), EQ-5D index score (ES = 1.06), H&Y score (ES = 0.82), and the EQ-VAS score (ES = 0.24).
CONCLUSION: Both the EQ-5D and PDQ-8 are responsive to changes in health burden of the Parkinson's disease over a 4-year period.

Entities:  

Mesh:

Year:  2010        PMID: 20204708     DOI: 10.1007/s11136-010-9615-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  14 in total

1.  Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial.

Authors:  Katia Noyes; Andrew W Dick; Robert G Holloway
Journal:  Med Decis Making       Date:  2004 Sep-Oct       Impact factor: 2.583

2.  Validation of PDQ-8 as an independent instrument in English and Chinese.

Authors:  Louis C S Tan; Puay-Ngoh Lau; Wing-Lok Au; Nan Luo
Journal:  J Neurol Sci       Date:  2007-03-02       Impact factor: 3.181

3.  Is EQ-5D a valid quality of life instrument in patients with Parkinson's disease? A study in Singapore.

Authors:  Nan Luo; Serena Low; Puay-Ngoh Lau; Wing-Lok Au; Louis C S Tan
Journal:  Ann Acad Med Singapore       Date:  2009-06       Impact factor: 2.473

4.  PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures.

Authors:  V Peto; C Jenkinson; R Fitzpatrick
Journal:  J Neurol       Date:  1998-05       Impact factor: 4.849

5.  Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.

Authors:  H Reichmann; J Boas; D Macmahon; V Myllyla; A Hakala; K Reinikainen
Journal:  Acta Neurol Scand       Date:  2005-01       Impact factor: 3.209

6.  Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.

Authors:  M Reuther; E A Spottke; J Klotsche; O Riedel; H Peter; K Berger; O Athen; R Köhne-Volland; R C Dodel
Journal:  Parkinsonism Relat Disord       Date:  2006-10-19       Impact factor: 4.891

7.  Modeling valuations for EuroQol health states.

Authors:  P Dolan
Journal:  Med Care       Date:  1997-11       Impact factor: 2.983

Review 8.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

9.  Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson's Disease Questionnaire (PDQ-8).

Authors:  Nan Luo; Louis C S Tan; Yingjiao Zhao; Puay-Ngoh Lau; Wing-Lok Au; Shu Chuen Li
Journal:  Mov Disord       Date:  2009-01-30       Impact factor: 10.338

10.  Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore.

Authors:  Louis C S Tan; Nan Luo; Mohammed Nazri; Shu Chuen Li; Julian Thumboo
Journal:  Parkinsonism Relat Disord       Date:  2004-12       Impact factor: 4.891

View more
  12 in total

1.  Population norms for the EQ-5D index scores using Singapore preference weights.

Authors:  Edimansyah Abdin; Mythily Subramaniam; Janhavi Ajit Vaingankar; Nan Luo; Siow Ann Chong
Journal:  Qual Life Res       Date:  2014-11-14       Impact factor: 4.147

Review 2.  Can The EQ-5D Detect Meaningful Change? A Systematic Review.

Authors:  Nalin Payakachat; Mir M Ali; J Mick Tilford
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

3.  Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's disease.

Authors:  Sabrina Schröder; Peter Martus; Per Odin; Marion Schaefer
Journal:  Int J Clin Pharm       Date:  2012-07-19

4.  Measuring health-related quality of life among adults in Singapore: population norms for the EQ-5D.

Authors:  Edimansyah Abdin; Mythily Subramaniam; Janhavi Ajit Vaingankar; Nan Luo; Siow Ann Chong
Journal:  Qual Life Res       Date:  2013-04-03       Impact factor: 4.147

Review 5.  Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.

Authors:  Yiqiao Xin; Emma McIntosh
Journal:  Qual Life Res       Date:  2016-10-24       Impact factor: 4.147

6.  Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.

Authors:  Miguel Ángel García-Gordillo; Borja del Pozo-Cruz; José Carmelo Adsuar; Fernando Ignacio Sánchez-Martínez; José María Abellán-Perpiñán
Journal:  Qual Life Res       Date:  2013-11-22       Impact factor: 4.147

7.  Quality of life assessed with EQ-5D in patients undergoing glioma surgery: what is the responsiveness and minimal clinically important difference?

Authors:  Lisa Millgård Sagberg; Asgeir S Jakola; Ole Solheim
Journal:  Qual Life Res       Date:  2013-12-07       Impact factor: 4.147

8.  Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factors.

Authors:  Irene J Higginson; Wei Gao; Tariq Zaffer Saleem; K Ray Chaudhuri; Rachel Burman; Paul McCrone; Peter Nigel Leigh
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Deep Brain Stimulation Can Preserve Working Status in Parkinson's Disease.

Authors:  Gabriella Deli; István Balás; Tamás Dóczi; József Janszky; Kázmér Karádi; Zsuzsanna Aschermann; Ferenc Nagy; Attila Makkos; Márton Kovács; Edit Bosnyák; Norbert Kovács; Sámuel Komoly
Journal:  Parkinsons Dis       Date:  2015-07-30

10.  Palliative care for patients with Parkinson's disease: study protocol for a mixed methods study.

Authors:  Herma Lennaerts; Marieke Groot; Maxime Steppe; Jenny T van der Steen; Marieke Van den Brand; Dorian van Amelsvoort; Kris Vissers; Marten Munneke; Bastiaan R Bloem
Journal:  BMC Palliat Care       Date:  2017-11-25       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.